GRANTED

Vir Biotechnology Announces Initially Marketing and advertising Authorization for its First Commercial Merchandise, Sotrovimab, Granted in Australia

Tanya J. Montague 3 years ago

– 1st monoclonal antibody authorized in Australia – SAN FRANCISCO, Aug. 23, 2021 (Globe NEWSWIRE) — Vir Biotechnology, Inc. (Nasdaq: VIR) now declared the initially advertising and marketing authorization, granted in Australia, for its initial industrial solution, sotrovimab, formulated in partnership with GlaxoSmithKline (GSK). This announcement follows news shared by […]